Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00481988 · ClinicalTrials.gov registry record · Phase 1
Treating Depression With Transcranial Direct Current Stimulation (tDCS)
A Phase 1 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00481988: Completed Phase 1 study, sponsored by New York State Psychiatric Institute.
NCT00481988 is a Phase 1 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00481988, a Phase 1 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to see if transcranial direct current stimulation may improve the symptoms of depression.
Primary Outcome
The Hamilton Rating Scale for Depression (HRS,24 question version), is a standardized assessment tool for measuring severity of depression where 0 is the minimum score (no depressive symptoms) and 40 is the maximum (severe depression).I am reporting the number of participants with stable remission which is defined as an HDRS \< 10 for 2 weeks.
Interventions
- DEVICE transcranial direct current stimulation
- DEVICE iomed phoresor transcranial direct current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-01 |
| Phase | Phase 1 |
What the finished NCT00481988 record still lists
NCT00481988 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which transcranial direct current stimulation is the first listed.
NCT00481988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00481988 about?
NCT00481988 is a clinical study titled "Treating Depression With Transcranial Direct Current Stimulation (tDCS)". The purpose of this study is to see if transcranial direct current stimulation may improve the symptoms of depression.
What is the current status of trial NCT00481988?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2007-03. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00481988?
The interventions under investigation include: transcranial direct current stimulation (DEVICE), iomed phoresor transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT00481988?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00481988's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia